Concepedia

Matthew C. Riddle

MC

127

Publications

23.8K

Citations

64

H-Index

1925

Active since

Affiliations

Oregon Health & Science University(Current)

McMaster University

Hamilton Health Sciences

Population Health Research Institute

University of Toronto

Matthew C. Riddle is an author at Oregon Health & Science University specializing in medicine, diabetes, and metabolic syndrome.

ORCID

Top concepts

Publications per year

1925–2025

127

Publications

127

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Marc A. Pfeffer, Brian Claggett, Rafael Díaz et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

Deepak L. Bhatt, Michael Szarek, Philippe Gabríel Steg et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

, , +6

The Treat-to-Target Trial

Matthew C. Riddle, Julio Rosenstock, John Gerich · Diabetes Care · 2003 · 1.5K citations · Full text

Rows per page

1–5 of 127